Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine Effect on Hepatic Blood Flow in Pancreatic Surgery
NCT03965117Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of norepinephrine in intraoperative hypotension (IOH), sponsored by Ghent University Hospital. Primary endpoints: Change in hepatic blood flow during goal-directed hemodynamic therapy with norepinephrine and Change in hepatic blood pressures during goal-directed hemodynamic therapy with norepinephrine. Started May 2019; status: completed.
02
Drugs
norepinephrine
03
Conditions
intraoperative hypotension (IOH)
Beyond the preview
Go deeper on NCT03965117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965117.